Bleeding control after single-ray amputation: Hemocoll vs Avitene vs bone wax
Official title: A Multicentre, Prospective, Randomized, Controlled, Three-Arm Superiority Trial Comparing Hemocoll® FTC, Avitene™ MCH, and Conventional Bone Wax for Cancellous Bone Bleeding Following Single-Ray Amputation
Run by Adichunchanagiri Institute of Medical Sciences, B G Nagara · NCT07788846 · Data updated 2026-11-12
This trial tests whether Hemocoll, Avitene, or bone wax better stop bleeding from exposed bone after a planned single-ray amputation in adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 135 (estimated) |
| Sponsor | Adichunchanagiri Institute of Medical Sciences, B G Nagara Academic / other |
| Locations | 3 sites (Kolār, Karnataka and 2 other locations) |
| Status | Recruiting |
| Started | September 5, 2026 |
| Main results expected | January 2027 |
| Study ends | January 2027 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT07788846 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) undergoing planned single-ray amputation with exposed cancellous bone and active bleeding after tourniquet release.
✕Probably not a fit
Patients with bleeding conditions, hypersensitivity to study materials, or undergoing procedures where cancellous bone bleeding cannot be assessed may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, prospective randomized trial compares three topical hemostatic options for controlling cancellous bone bleeding after tourniquet release in adults undergoing planned single-ray amputation. Participants are randomized 1:1:1 to Hemocoll fibrillar Type-I collagen, Avitene microfibrillar collagen hemostat, or conventional bone wax, with a standardized compression protocol applied to the treated surface. The primary endpoint is complete hemostasis within a time frame specific to the affected bone (phalanx, metacarpal, or metatarsal). Secondary comparisons include Hemocoll versus bone wax and Avitene versus bone wax. The study aims to enroll 135 participants across three tertiary centers in Karnataka, India.
Why it matters
Potential benefit: If successful, patients may experience more reliable bleeding control after amputation, potentially reducing recovery time and complications.
How similar studies have gone: Previous work with topical hemostats suggests potential benefits in bone bleeding, but direct head-to-head data in this exact setting are limited, making this study relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years. * Planned surgical single-ray amputation involving one or more phalangeal, metacarpal or metatarsal bone segments. * Presence of an exposed cancellous bone surface following planned bone transection. * Ability to undergo the standardized operative protocol. * Ability to provide written informed consent. * Willingness to comply with postoperative follow-up Exclusion Criteria: * Known congenital or acquired bleeding disorder. * Severe uncorrected coagulopathy. * Severe thrombocytopenia considered clinically significant by the treating team. * Active major haemorrhage unrelated to the operative field. * Requirement for major vascular reconstruction during the procedure. * Procedures in which standardized assessment of cancellous bone bleeding is impossible. * Known hypersensitivity to bovine or ovine collagen or to bone wax. * Previous severe adverse reaction to the study haemostatic materials. * Simultaneous multiple unrelated amputation procedures where attribution of bleeding cannot be standardized. * Inability to obtain informed consent. * Any condition considered by the investigator to make participation unsafe or to compromise the integrity of the trial.
Where it's running
-
Sri Devaraj Urs Medical College
Kolār, Karnataka, India Recruiting -
Adichunchanagiri Institute of Medical Sciences
Mandya, Karnataka, India Recruiting -
Mysore Medical College and Research Institute
Mysuru, Karnataka, India Recruiting
Study contacts
- Study coordinator: Naveen Narayan, MS, MCh
- Email: naveen_uno1@yahoo.co.in
- Phone: 9980023372
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Simplified Tranexamic Acid Regimen for Trauma with Hemorrhage
This trial tests a simplified TXA dosing approach to see if it safely helps adults with major trauma and significant bleeding.
-
NasoAid vs NasoPore after Nasal Surgery
This study tests whether collagen-based NasoAid® nasal packing works as well as the synthetic NasoPore for stopping bleeding after nasal surgery in adults.
-
Appropriateness of Hemostatic Agent Use in Cardiovascular Surgery
This study tests how well surgeons’ choices about topical hemostatic agents match current guidelines in cardiac and vascular surgery at one Milan hospital.
-
Tailored lower‑intensity blood thinner plan after left atrial appendage closure to prevent stroke
This project tests whether people with non‑valvular atrial fibrillation who get a left atrial appendage closure can stop blood thinners after taking low‑dose apixaban (2.5 mg twice daily) for 3 months, compared with people who stay on standard‑dose DOACs.
-
Comparing periarticular vasoconstrictor infiltration and erector spinae plane block to reduce bleeding and pain in lumbar fusion
This trial will try periarticular vasoconstrictor infiltration versus erector spinae plane block to see if one reduces blood loss and postoperative pain in adults having lumbar fusion surgery.
-
Catheter ablation plus LAAC vs anticoagulation in frail elderly A-fib patients
This study tests whether adding left atrial appendage closure to ablation is as good as using long-term blood thinners in frail people aged 75 and up with atrial fibrillation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.